TECHNOLOGY
Long live the mechanical keyboard
TechCrunchFriday, October 9, 2026 at 10:08 PM
RedScroll Brief
Keychron made a name for itself after launching on Kickstarter in 2017. Today, it offers the value K2 model as well as a variety of other versions, including one with an all-wood body.
RedScroll Signal
- Impact
- High
- Category
- Technology
- Market relevance
- Moderate
- Why it matters
- Technology shifts change how people work, communicate, and build — often faster than policy can follow. Keychron made a name for itself after launching on Kickstarter in 2017. Today, it offers the value K2 model as well as a variety of other versions, including one with an all-wood body. Secondary effects may show up in markets and supply chains linked to Long and Technology.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Keychron made a name for itself after launching on Kickstarter in 2017. Today, it offers the value K2 model as well as a variety of other versions, including one with an all-wood body.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
TechCrunch reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
TechCrunch published: Long live the mechanical keyboard
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Long and Technology.
More on
Related stories
- Xona’s commercial GPS alternative is about to go live
TechCrunchTECHNOLOGY
- The Download: AI’s refusal problem and weight-loss drug side effects
MIT Technology ReviewTECHNOLOGY
- The Download: AI roadblocks for humanoids and portable rubber dams
MIT Technology ReviewTECHNOLOGY
- The Download: weight-loss drugs slowing aging and carbon dioxide batteries
MIT Technology ReviewTECHNOLOGY
- AI coding agents generate more code, but not more software
Ars TechnicaTECHNOLOGY
- Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial
Ars TechnicaTECHNOLOGY
Source
TechCrunch
Original reporting by TechCrunch. RedScroll provides an extractive briefing only.